A LC-MS/MS method for concurrent determination of nicotine metabolites and role of CYP2A6 in nicotine metabolism in U937 macrophages: Implications in oxidative stress in HIV + smokers

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 1, 2012, Pages 289-299

  Jin, Mengyao ^a   Earla, Ravinder ^a   Shah, Ankit ^a   Earla, Rajya L ^a   Gupte, Raeesa ^a   Mitra, Ashim K ^a   Kumar, Anil ^a   Kumar, Santosh ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

CYP2A6; HIV 1; LC MS MS; Macrophages; Nicotine; Oxidative stress

Indexed keywords

COTININE; CYTOCHROME P450 2A6; KETONE; NICOTINE; NITROSAMINE KETONE; UNCLASSIFIED DRUG;

ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; HIV-1; HUMANS; MACROPHAGES; NICOTINE; NITROSAMINES; OXIDATIVE STRESS; SMOKING; TANDEM MASS SPECTROMETRY;

EID: 84859991085     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-011-9283-6     Document Type: Article

References (48)

1. Abbud RA, Finegan CK, Guay LA, Rich EA (1995) Enhanced production of human immunodeficiency virus type 1 by in vitroinfected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 172:859-863
2. Aquaro S, Ronga L, Pollicita M, Antinori A, Ranazzi A, Perno CF (2005) Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage. J Neurovirol Suppl 3:58-66
3. Bao Z, He XY, Ding X, Prabhu S, Hong JY (2005) Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab Dispos 33:258-261 (Pubitemid 40216593)
4. Bao M, Joza P, Rickert WS, Lauterbach JH (2010) An improved headspace solid-phase microextraction method for the analysis of free-base nicotine in particulate phase of mainstream cigarette smoke. Anal Chim Acta 663:49-54
5. Benowitz NL (2009) Pharmacology of nicotine: addiction, smokinginduced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57-71
6. Benowitz NL, Hukkanen J, Jacob P 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 192:29-60
7. Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG (1998) Preferential effects of nicotine and 4-(N-methyl-N-nitrosamine)- 1-(3-pyridyl)-1-butanone on mitochondrial glutathione Stransferase A4-4 induction and increased oxidative stress in the rat brain. Biochem Pharmacol 56:831-839 (Pubitemid 28458977)
8. Boelaert JR, Piette J, Weinberg GA, Sappey C, Weinberg ED (1996a) Iron and oxidative stress as a mechanism for the enhanced production of human immunodeficiency virus by alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 73:1045-1047
9. Boelaert JR, Weinberg GA, Weinberg ED (1996b) Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 5:36-46 (Pubitemid 26038608)
10. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD (2005) Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 7:511-522 (Pubitemid 41600909)
11. Byrd GD, Ogden MW (2003) Liquid chromatographic/tandem mass spectrometric method for the determination of the tobaccospecific nitrosamine metabolite NNAL in smokers' urine. J Mass Spectrom 38:98-107 (Pubitemid 36157762)
12. Byrd GD, Chang KM, Greene JM, deBethizy JD (1992) Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Drug Metab Dispos 20:192-197
13. Byrd GD, Davis RA, Ogden MW (2005) A rapid LC-MS-MS method for the determination of nicotine and cotinine in serum and saliva samples from smokers: validation and comparison with a radioimmunoassay method. J Chromatogr Sci 43:133-140 (Pubitemid 40389551)
14. Chuang CH, Hu ML (2006) Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4- (methyl-nitrosamino)-1-(3- pyridyl)-1-butanone and ultraviolet A. Environ Mol Mutagen 47:73-81
15. Curvall M, Kazemi-Vala E, Enzell CR (1982) Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. J Chromatogr 232:283-293 (Pubitemid 13190678)
16. Davis RA (1986) The determination of nicotine and cotinine in plasma. J Chromatogr Sd 24:134-141 (Pubitemid 16100678)
17. Davis RA, Curvall M (1999) Determination of nicotine and its metabolites in biological fluids: in vivo studies. In: Gorrod JW, Jacob P (eds) Analytical determination of nicotine and related compounds and their metabolites. Elsevier Science, Amsterdam, pp 583-643
18. Demizu Y, Sasaki R, Trachootham D, Pelicano H, Colacino JA, Liu J, Huang P (2008) Alterations of cellular redox state during NNKinduced malignant transformation and resistance to radiation. Antioxid Redox Signal 10:951-961 (Pubitemid 351301371)
19. Earla R, Boddu SH, Cholkar K, Hariharan S, Jwala J, Mitra AK (2010) Development and validation of a fast and sensitive bioanalytical method for the quantitative determination of glucocorticoids-quantitative measurement of dexamethasone in rabbit ocular matrices by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 52:525-533
20. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, Gandhi M, Mocharnuk RS, Anastos K (2006) Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 96:1060-1065 (Pubitemid 43825275)
21. Flammang AM, Gelboin HV, Aoyama I, Gonzalez FJ, McCoy GD (1992) Nicotine metabolism by cDNA-expressed human cytochrome P450. Biochem Arch 8:1-8
22. Ghosh D, Mishra MK, Das S, Kaushik DK, Basu A (2009) Tobacco carcinogen induces microglial activation and subsequent neuronal damage. J Neurochem 110:1070-1081
23. Hecht SS, Hochalter JB, Villalta PW, Murphy SE (2000) 2'- Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci USA 97:12493-12497
24. Jin M, Arya P, Patel K, Singh B, Silverstein P, Bhat H, Kumar A, Kumar S (2011) Effect of alcohol on drug efflux protein and drug metabolic enzymes in U937 macrophages. Alc Clin Exp Res 35:1-8
25. Kadlubar S, Anderson JP, Sweeney C, Gross MD, Lang NP, Kadlubar FF, Anderson KE (2009) Phenotypic CYP2A6 variation and the risk of pancreatic cancer. J Pancr 10:263-270
26. Kamataki T, Fujita K, Nakayama K, Yamazaki Y, Miyamoto M, Ariyoshi N (2002) Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. Drug Metab Rev 34:667-676 (Pubitemid 35006071)
27. Kedzierska K, Crowe SM (2002) The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 9:1893-1903 (Pubitemid 35230257)
28. Kumar S, Earla R, Jin M, Mitra AK, Kumar A (2010) Effect of ethanol on spectral binding, inhibition, and activity of CYP3A4 with an antiretroviral drug nelfinavir. Biochem Biophys Res Commun 402:163-167
29. Lämsä V, Levonen AL, Leinonen H, Ylä-Herttuala S, Yamamoto M, Hakkola J (2010) Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. Chem Res Toxicol 23:977-985
30. Lemberger L, Axelrod J, Kopin IJ (1971) The disposition and metabolism of tryptamine and the in vivo formation of 6- hydroxytryptamine in the rabbit. J Pharmacol Exp Ther 177:169-176
31. Lu Y, Zhuge J, Wu D, Cederbaum AI (2011) Ethanol-induction of Cytochrome P450 2A5: Permissive Role for CYP2E1. Drug Metab Dispos 39:330-336
32. Mahapatra SK, Das S, Bhattacharjee S, Gautam N, Majumdar S, Roy S (2009) In vitro nicotine-induced oxidative stress in mice peritoneal macrophages: a dose-dependent approach. Toxicol Mech Methods 19:100-108
33. Marclay F, Saugy M (2010) Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players. J Chromatogr A 1217:7528-7538
34. Miller EI, Norris HR, Rollins DE, Tiffany ST, Wilkins DG (2009) A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 878:725-737
35. Montaner LJ, Crowe SM, Aquaro S, Perno CF, Stevenson M, Collman RG (2006) Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. J Leukoc Biol 80:961-964 (Pubitemid 44646301)
36. Mwenifumbo JC, Tyndale RF (2007) Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics 8:1385-1402 (Pubitemid 350162852)
37. Rock RB, Gekker G, Aravalli RN, Hu S, Sheng WS, Peterson PK (2008) Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-beta 1. J Neuroimmune Pharmacol 3:143-149
38. Savarino A, Pescarmona GP, Boelaert JR (1999) Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 17:279-287
39. Sellers EM, Tyndale RF, Fernandes LC (2003) Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discov Today 8:487-493 (Pubitemid 36724582)
40. Smith TJ, Stoner GD, Yang CS (1995) Activation of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res 55:5566-5573
41. Smith TJ, Liao AM, Liu Y, Jones AB, Anderson LM, Yang CS (1997) Enzymes involved in the bioactivation of 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis 18:1577-1584 (Pubitemid 28134782)
42. Sopori ML, Kozak W (1998) Immunomodulatory effects of cigarette smoke. J Neuroimmunol 83:148-156 (Pubitemid 28280961)
43. US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation, Last accessed on May 2001.
44. von Weymarn LB, Chun JA, Hollenberg PF (2006) Effects of benzyl and phenethyl isothiocyanate on P450s 2A6 and 2A13: potential for chemoprevention in smokers. Carcinogenesis 27:782-790
45. Wong HL, Zhang X, Zhang QY, Gu J, Ding X, Hecht SS, Murphy SE (2005) Metabolic activation of the tobacco carcinogen 4- (methylnitrosamino)-(3- pyridyl)-1-butanone by cytochrome P450 2A13 in human fetal nasal microsomes. Chem Res Toxicol 18:913-918 (Pubitemid 40880879)
46. Yildiz D, Ercal N, Armstrong DW (1998) Nicotine enantiomers and oxidative stress. Toxicology 130:155-165 (Pubitemid 28488583)
47. Yokota S, Higashi E, Fukami T, Yokoi T, Nakajima M (2011) Human CYP2A6 is regulated by nuclear factor-erythroid 2 related factor 2. Biochem Pharmacol 15:289-294
48. Zhang W, Kilicarslan T, Tyndale RF, Sellers EM (2001) Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro. Drug Metab Dispos 29:897-902 (Pubitemid 32488648)